SINO BIOPH.SUBDIV.HD-,025
SINO BIOPH.SUBDIV.HD-,025/ KYG8167W1380 /
SMZ1
14.06.2024 11:37:54
|
Zm.
+0,0190
|
Wolumen |
Bid11:37:55 |
Ask11:37:55 |
Kapitalizacja Rynkowa |
St. dywidendy |
Wskaźnik C/Z |
0,3409EUR
|
+5,90%
|
8 850 Obrót: 3 013,5450 |
0,3209Wolumen Bid: 3 120 |
0,3410Wolumen Ask: 3 120 |
6,11 mldEUR |
- |
- |
Opis działalności
Sino Biopharmaceutical Limited, together with its subsidiaries, is a research and development driven pharmaceutical conglomerate in the Republic of China. Its business encompasses a fully integrated chain in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemical medicines for treating tumours, liver disease, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedic diseases. In order to enhance our sustainable competitiveness, the Group attaches great importance to R&D breakthroughs and is positioned as an industry leader in terms of R&D expenditures and product innovation.
Zarząd & Rada nadzorcza
CEO |
Tse Eric SY |
Zarząd |
Li Chunling, Theresa Tse, Tse Hsin, Chen,Sean, Ben Toogood, Jin Song, George Orphanides |
Rada nadzorcza |
Cheng Cheung Ling, Theresa Tse, Tse, Eric S Y, Tse Hsin, Tian Zhoushan, Li Mingqin, Lu Zhengfei, Li Dakui, Lu Hong, Zhang Lu Fu, LI Kwok Tung Donald |
Dane firmy
Nazwa: |
Sino Biopharmaceutical Ltd. |
Adres: |
Rm 4109, Office Tower, Convention Plaza, 1 Harbour Road,Wanchai, Hong Kong |
Telefon: |
+852-2802-9886 |
Fax: |
+852-2880-0847 |
E-mail: |
info@sino-biopharm.com
|
Internet: |
www.sinobiopharm.com |
Przemysł: |
Biotechnologia |
Sektor: |
Biotechnologia |
Podsektor: |
Biotechnologia |
Koniec roku finansowego: |
31.12 |
Free float: |
51,86% |
Data IPO: |
08.12.2003 |
Relacje inwestorskie
Nazwa: |
- |
Telefon: |
- |
Fax: |
- |
E-mail: |
-
|
Kalendarz korporacyjny
Tydz. 27 | 05.07.2024
Wypłata Dywidendy
|